XML 29 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Redeemable Noncontrolling Interest (Tables)
 6 Months Ended
Jun. 30, 2024
Noncontrolling Interest [Abstract]  
Summary of company and transfers to noncontrolling interest The following is a summary of net income attributable to the Company and transfers to noncontrolling interest (in thousands):

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net loss available to Class A ordinary shareholders

$

(12,506

)

 

$

(9,118

)

 

$

(21,998

)

 

$

(18,783

)

(Increase)/Decrease in ProKidney Corp. accumulated deficit for impact of
   subsidiary equity-based compensation

 

1,374

 

 

 

2,762

 

 

 

3,014

 

 

 

5,219

 

(Increase)/Decrease in ProKidney Corp. additional paid-in capital for exchange
   of Common Units in ProKidney LP for Class A ordinary shares

 

(12,613

)

 

 

–

 

 

 

(14,902

)

 

 

–

 

(Increase)/Decrease in ProKidney Corp. additional paid-in capital for vesting of
   Restricted Common Units in ProKidney LP

 

22,745

 

 

 

(725

)

 

 

14,073

 

 

 

(4,478

)

Change from net loss available to Class A ordinary shareholders and change
   in ownership interest in ProKidney LP

$

(1,000

)

 

$

(7,081

)

 

$

(19,813

)

 

$

(18,042

)